Baseline PSPRS was higher in individuals with CBS-FTLD than in those with CBS-AD (Table), but no differences were seen in rates of progression longitudinally (Figure 4A and B; eTable 4 in Supplement 1). The gene discussed is CBS; the disease is Alzheimer disease.